Indoco Remedies scores major FDA win with exclusive approval for Lofexidine Tablets
Indoco Remedies Limited has achieved a pivotal milestone with the final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lofexidine Tablets, 0.18 mg. This approval authorizes Indoco to market a generic equivalent of Lucemyra Tablets, 0.18 mg, which are manufactured by USWM, LLC. This announcement includes […]